Pharmacogenomic Testing May Curb Drug Interactions in MDD
In major depressive disorder (MDD), pharmacogenomic tests can help reduce drug-gene interactions related to antidepressants, leading to better selection and optimal dosing of the med, new research suggests.
Source: medscape.com